November 7, 2019
Takeda Pharmaceutical has opened a new manufacturing plant for Dengue vaccines in Singen, Germany, with an investment of over €130 million, the company said on November 5. The new facility will handle formulation, fill, labeling, and secondary packaging. Takeda’s tetravalent...read more